Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®).
Lee MK, Mitchell SA, Basch E, Mazza GL, Langlais BT, Thanarajasingam G, Ginos BF, Rogak L, Meek EA, Jansen J, Deal AM, Carr P, Blinder VS, Jonsson M, Mody GN, Mendoza TR, Bennett AV, Schrag D, Dueck AC. Lee MK, et al. Among authors: mendoza tr. Qual Life Res. 2024 Nov 6. doi: 10.1007/s11136-024-03819-5. Online ahead of print. Qual Life Res. 2024. PMID: 39503942
Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) in a diverse cancer sample.
Mead-Harvey C, Basch E, Rogak LJ, Langlais BT, Thanarajasingam G, Ginos BF, Lee MK, Yee C, Mitchell SA, Minasian LM, Mendoza TR, Bennett AV, Schrag D, Dueck AC, Mazza GL. Mead-Harvey C, et al. Among authors: mendoza tr. Clin Trials. 2024 Oct 23:17407745241286065. doi: 10.1177/17407745241286065. Online ahead of print. Clin Trials. 2024. PMID: 39440720 Free article.
Assessing sleep in primary brain tumor patients using smart wearables and patient-reported data: Feasibility and interim analysis of an observational study.
Pascoe MM, Wollet AR, De La Cruz Minyety J, Vera E, Miller H, Celiku O, Leeper H, Fernandez K, Reyes J, Young D Jr, Acquaye-Mallory A, Adegbesan K, Boris L, Burton E, Chambers CP, Choi A, Grajkowska E, Kunst T, Levine J, Panzer M, Penas-Prado M, Pillai V, Polskin L, Wu J, Gilbert MR, Mendoza T, King AL, Shuboni-Mulligan D, Armstrong TS. Pascoe MM, et al. Among authors: mendoza t. Neurooncol Pract. 2024 May 24;11(5):640-651. doi: 10.1093/nop/npae048. eCollection 2024 Oct. Neurooncol Pract. 2024. PMID: 39279778 Free article.
Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma.
Cleeland CS, Keating KN, Cuffel B, Elbi C, Siegel JM, Gerlinger C, Symonds T, Sloan JA, Dueck AC, Bottomley A, Wang XS, Williams LA, Mendoza TR. Cleeland CS, et al. Among authors: mendoza tr. Sci Rep. 2024 Jun 27;14(1):14839. doi: 10.1038/s41598-024-62307-5. Sci Rep. 2024. PMID: 38937473 Free PMC article. Clinical Trial.
309 results